Fungal infections, long neglected by global health policy, could spark major public health crisis in coming decades ...

An Indian anesthetist and members of a surgical team attend to a patient suffering from mucormycosis in June ... growing increasingly resistant to treatment," WHO said. A person holds a head ...

In it, they discuss the use of monoclonal antibodies to target a key fungal cell surface protein, CotH, which enables the fungus to invade human cells and cause mucormycosis. Their findings will ...

This patient was treated at New York Presbyterian/Weill Cornell Medical Center and was discharged after just six weeks of treatment with MAT2203, Matinas’ oral formulation of the potent ...

At 25 weeks pregnant, Kayla Lindamood caught COVID-19. She developed mucormycosis, an often fatal infection in her lungs. Somehow she survived. In April 2021, Kayla Lindamood, then 31, was 25 ...

Mucormycosis is a life-threatening fungal ... placebo for both lung and brain tissues). The combination treatment of SCY-247 plus LAMB demonstrated the greatest reduction in fungal burden and ...

Cresemba is now the only azole antifungal treatment approved by the FDA for use in pediatric patients as young as 1 year of age with invasive aspergillosis and invasive mucormycotic. The FDA has ...

These findings provide the rationale for testing the efficacy of Blina for first-line treatment in children with B-ALL ... 7 = G4), including CNS (n = 2), pulmonary mucormycosis (n = 1), and ...